期刊文献+

血清尿酸水平与冠心病关系的探讨

A Study on the Correlation Between Serum Uric Acid Lever and Coronary Heart Disease
下载PDF
导出
摘要 目的:探讨空腹血清尿酸(UA)水平与冠心病(CHD)的关系。方法:采用全自动生化分析仪测定血清UA水平,检验急性冠状动脉综合征(ACS)组、稳定型心绞痛(SAP)组和对照组中UA血清浓度的差异。结果:ACS组和SAP组UA血清浓度均高于对照组(P<0.01):ACS组UA血清浓度高于SAP组(P<0.05)。结论:CHD患者UA血清浓度升高可促进动脉粥样斑块的不稳定,导致ACS的发生,参与CHD的发生发展过程。 Objective:To investigate the relationship between serum urie acid(UA) and coronary heart disease(CHD).Methods:To detect the serum UA concentration by Full Automatic Biochemical Analyzer and analysis the differences among patients with acute coronary syndrome (ACS),stable angina pectoris(SAP)and people in control group.Results:The serum UA concentration in patients with ACS and SAP was much higher than that in people in control group(P〈0.01).The serum UA concentration in patients with ACS was higher than that in patients with SAP(P〈0.05).Conclusions:The increase in serum UA concentration in patieats with CHD might contribute to the instability of atheromatous plaque in artery and could induce the happening of ACS and took part in the development of CHD.
出处 《中国医药导刊》 2009年第11期1912-1913,共2页 Chinese Journal of Medicinal Guide
关键词 冠心病 血清尿酸 关系 Coronary heart disease Serum uric acid Relationship
  • 相关文献

参考文献10

  • 1Bickel C,Rupprecht HJ,Blankenberg S,et al.Serum uricacid as an independent predictor of mortality in patient swith angiographically proven coronary artery disease [J] .Am J Cardiol,2002 ;89(1 ): 12.
  • 2Verdecchia P, Schillaci O,Reboldi GP, et al.Relation between serum uric acid and risk of cardiovascular disease in csseutial hypertension.The PIUMA Study[J].Hypertension,2000;36(6): 1072-1078.
  • 3康晓新,宋卓,曲家珍.冠心病患者血尿酸和血脂水平分析[J].中国心血管杂志,2004,9(6):440-441. 被引量:2
  • 4Puddu PE,Ianti M,Menotti A,et al.Serum uric acid for short-term prediction of cardiovascular disease incidence in the Gubbio population study[J].Acta Cardiol,2001 ;56(4):243-251.
  • 5Jeremy G Wheeler,Kelsey D,M Juzwishin,et al.Serum uric acid and coronary heart disease in 9 458 incident cases and 155 084 controls: prospective study and meta-analysis[J].Plos Med,2005;2(3):76.
  • 6Sevanian A,Davies K,Hochstein P.Serum urate as an antioxidant for ascorbic acid. Am J Clin Nutr,1991;54:1129S-1134S.
  • 7Ward HJ.Uric acid as an independent risk factor in the treatment of hypertension[J] .Lancet, 1998 ;352(9129) :670-671.
  • 8De Scheeder IK,Van de KraayAM,Lamrs JM,et al.Myocardial malodialdehyde and uric acid release after short-lasting corunary occlusions during angiop lasty:Potentialmechanisms for free radical generation.Am J Cardiol, 1991 ;68(4): 392-395.
  • 9孙余华,裴卫东,惠汝太.炎症与动脉粥样硬化基础和临床研究的新进展[J].中国循环杂志,2003,18(3):232-235. 被引量:30
  • 10Nakamura T,Kawagoe Y, Matsuda T, et al. Effects of LDL apheresis and vitamin E-modified membrane on carotid antherosclerosis in hemodialyzed patients with arteriosclerosis obliterans[J].Kidney Blood Press Res,2003;26(1): 185-191.

二级参考文献17

  • 1Libby P, Ridker PM, Maseri A. Inflammation and atherosclercsis. Circulation, 2002, 105: 1135-1143.
  • 2Kharbanda RK, Walton B, Allen M, et al. Prevention of inflammation-induced endothelial dysfunction: a novel vasculo-protective action of aspirin.Circulation, 2002, 105: 2600-2604.
  • 3Nakajima T, Schuhe S, Warrington KJ, et al. T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation, 2002, 105: 570-575.
  • 4Verma S, Li SH, Badiwala MV, et al. Endothelin antagonism and interleuldn-6 inhibition attenuate the proatherogenic effects of C-reactlve protein.Circulation. 2002, 105: 1890-1896.
  • 5Sampietro T, Bigazzi F, Dal Pino B, et al. Increased plasma C-reactive protein in familial hypoalphalipoproteinemia: a proinflammation condition? Circulation, 2002, 105: 11-14.
  • 6Rajamannan NM, Subramanian M, Springett M, et al. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation, 2002, 105: 2660-2665.
  • 7Hayaishi-Okano R, Yamaski Y, Katakami N, et al. Elevated C-reactive protein associates witheady-stage carotid atherosclerosis in young subjects with type 1 diabetes. Diabetes Care, 2002, 25: 1432-1438.
  • 8Prasad A, Zhu J, Halcox JP, et al. Predisposition to atheroscleroeis by infections: role of endothelial dysfunction. Circulation, 2002, 106: 184-190.
  • 9Parchure N, Zouridakis EG, Kaski JC. Effect of azithromycin treatment on endothelial function in patients with coronary artery disease and evidence of Chlamydia pneumoniae infection. Circulation, 2002, 105: 1298-1303.
  • 10Wiesli P, Czerwenka W, Meniconi A, et al. Roxithromycin treatment prevents progression of peripheral arterial occlusive disease in Chlamydia pneumoniae seropositive men: a randomized, double-blind, placebo-controlled trial. Circulation, 2002, 105: 2646-2652.

共引文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部